Chronic musculoskeletal pain disorder and its associated mental health conditions, comorbidities and psychosocial risk predictors

Table 1 Demographic and treatment trials’ characteristics of the studied patients, n (%)/mean ± SD

Demographics	Patients (n = 160)
Gender
Male	30 (18.75)
Female	130 (81.25)
Age (years)	46.63 ± 6.23
Range	20-60
Age groups
20-30 years	13 (18.13)
31-40 years	26 (16.25)
41-50 years	86 (53.75)
51-60 years	35 (21.88)
Marital status
Single	20 (12.5)
Married	90 (56.25)
Widow	30 (18.75)
Divorced	20 (12.5)
Residence
Rural	100 (62.5)
Urban	60 (37.5)
Socioeconomic status
Middle	110 (68.75)
High	50 (31.25)
Body mass index
Normal	60 (37.5)
Overweight	60 (37.5)
Obese	40 (25)
Occupation1
For males (n = 30)
Labor work	30 (100)
For females (n = 130)
Housewife	110 (84.62)
Worker	20 (15.38)
Comorbid medical conditions
Iron deficiency anemia	64 (40)
Hypothyroidism	27 (16.88)
Treatment trials to relief pain
Pharmacological
NSAIDs	160 (100)
Muscle relaxants	25 (15.63)
Systemic steroids	60 (37.5)
Local steroids/anesthetics	20 (12.5)
Antidepressants	90 (56.25)
Antiepileptic drugs	60 (18.75)
Sleep inducing medications	75 (46.88)
Substance abuse	20 (66.67)
Non-pharmacological
Physiotherapy	45 (28.13)
Acupuncture	30 (15.63)
Folk remedies	90 (56)
Psychotherapy	0

¹Percentages were calculated in relation to gender.

NSAIDs: Non-steroidal anti-inflammatory drugs.